Non-GAAP full-year EPS -- $2.84, up 81% year over year; GAAP full-year EPS was $3.70. Operating expenses -- Fourth quarter GAAP: $744 million; fourth quarter non-GAAP: $517 million; first quarter ...

Total sales growth (fiscal Q4, period ended Jan. 31, 2026) -- 11%, on top of 10% growth in the prior year, demonstrating consecutive double-digit quarterly increases. Adjusted EPS (fiscal Q4) -- $4.99 ...

Chicago’s defensive line underperformed in 2025, but how much of that was due to the 3rd-year player out of Florida?

The confusion around Wichita State’s senior day festivities this weekend comes down to one key distinction: class standing on ...

Good morning, and welcome to the ImmuCell Corporation Conference Call to discuss Unaudited Fourth Quarter and Full Year 2025 Financial Results. Please note, this event is being recorded. I would now ...

Wall Street is in a downward pattern after days of volatility. Markets have been buffeted by developments in the conflict in Iran, now entering it's sixth day.

Those that solve artificially simplified problems where quantum advantage is meaningless. Those that provide no genuine quantum advantage when all costs are properly accounted for. This critique is ...

Q4 2025 Earnings Call February 27, 2026 3:30 AM ESTCompany ParticipantsDaniel ThomsonPhilippe Guillemot - Group Chairman ...